Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1634 1637 1677 1681
This examiner grants 79% of resolved cases
Kenneth R Horlick has managed 1049 resolved cases in Tech Center 1600. The examiner demonstrates an allowance rate of 78.9 percent, which is relatively high for this tech center. This high rate suggests a favorable environment for applicants seeking patent protection. The median days to allowance of 898 indicates that successful applications typically reach a conclusion within that timeframe. Interviews appear to be a beneficial strategy, as evidenced by an interview lift of 15.3 percent.
This metric shows that engaging with the examiner can further increase the already high 78.9 percent allowance rate. The 1049 resolved cases provide a robust dataset for predicting future outcomes in Art Unit 1600. The 898-day median pendency is a key factor for strategic planning. Applicants can use this figure to estimate the time required to navigate prosecution under this examiner. The combination of a high allowance rate and a significant interview lift makes Kenneth R Horlick a predictable figure in Tech Center 1600. Practitioners should consider early interviews to capitalize on the 15.3 percent lift and potentially expedite their cases.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19577221 | METHODS FOR PERFORMING ASSAYS ON INDIVIDUAL LIVE CELLS | Final Rejection | Cellanome, Inc. |
| 19577281 | METHODS FOR FORMING ENCLOSURES AND PERFORMING ASSAYS ON A CELL WITHIN AN ENCLOSURE | Non-Final OA | Cellanome, Inc. |
| 19538691 | METHODS FOR INCUBATING AND ANALYZING A CELL IN A COMPARTMENT OF A FLUIDIC DEVICE | Non-Final OA | Cellanome, Inc. |
| 19381382 | DEVICES AND METHODS FOR ANALYZING BIOLOGICAL SAMPLES | Non-Final OA | Cellanome, Inc. |
| 18303468 | TARGETED SEQUENCING | Final Rejection | Singular Genomics Systems, Inc. |
| 18419486 | CHROMOPHORE-BASED MEDICAL SYSTEM FOR DETECTING GENETIC VARIATIONS IN ANALYTES | Non-Final OA | California Institute of Technology |
| 19308103 | METHODS AND SYSTEMS FOR PROCESSING CELL-FREE SAMPLES | Final Rejection | CareDx, Inc. |
| 18494072 | METHODS FOR FAST NUCLEIC ACID AMPLIFICATION | Final Rejection | University of Utah Research Foundation |
| 18188092 | METHODS AND SYSTEMS FOR INTEGRATED ON-CHIP SINGLE-MOLECULE DETECTION | Non-Final OA | Nautilus Subsidiary, Inc. |
| 17678357 | GENE SIGNATURES FOR CANCER PROGNOSIS | Non-Final OA | MYRIAD GENETICS, INC. |
| 18168131 | FORCE-CONTROLLED NANOSWITCH ASSAYS FOR SINGLE-MOLECULE DETECTION IN COMPLEX BIOLOGICAL FLUIDS | Non-Final OA | Children's Medical Center Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy